by stemcellclub | Nov 9, 2026 | Stem Cell Therapy
Research Spotlight · Crohn’s Perianal Fistula A stem cell product made for one painful Crohn’s complication won approval in Europe in 2018. In 2024 it was pulled from the market. In 2026 the full trial data were finally published. Here is what happened,...
by stemcellclub | Nov 4, 2026 | Stem Cell Therapy
Research Spotlight · Heart Failure For 25 years, researchers have tried to fix failing hearts with stem cells. In 2026, two very different ideas made news: lab-grown heart muscle stitched onto the heart, and donor cells used to calm inflammation. Here is what the...
by stemcellclub | Nov 2, 2026 | Stem Cell Therapy
Research Spotlight · Stroke Stroke is the condition stem cell researchers have chased longer than almost any other. Thousands of patients have now been through clinical trials. Here is what the biggest randomized trials and the newest 2026 reviews actually show, why...
by stemcellclub | Oct 30, 2026 | Stem Cell Therapy
Research Spotlight · Macular Degeneration Dry macular degeneration slowly wipes out the layer of support cells under the retina. Researchers are now growing replacement cells from stem cells and placing them under the retina by surgery. Here is what the 2026 trial...
by stemcellclub | Oct 28, 2026 | Stem Cell Therapy
Research Spotlight · Lupus For 15 years, small open-label studies suggested that mesenchymal stem cells might help people with hard-to-treat lupus. In October 2026, the first U.S. multicenter, double-blind, placebo-controlled trial released its results. Here is what...
by stemcellclub | Oct 26, 2026 | Stem Cell Therapy
Research Spotlight · Spinal Cord Injury On October 15, 2026, an expert panel in Japan endorsed full approval of Stemirac, a stem cell product for spinal cord injury. It would be the first product in Japan to move from conditional approval to full approval. Here is...